- Report
- October 2024
- 139 Pages
Global
From €2662EUR$2,990USD£2,326GBP
- Report
- June 2025
- 136 Pages
Global
From €2269EUR$2,549USD£1,983GBP
€2670EUR$2,999USD£2,333GBP
- Report
- October 2025
Global
From €4362EUR$4,900USD£3,811GBP
- Report
- June 2025
- 100 Pages
Global
From €4362EUR$4,900USD£3,811GBP
- Report
- May 2025
- 100 Pages
Global
From €4362EUR$4,900USD£3,811GBP
From €4362EUR$4,900USD£3,811GBP
- Report
- April 2025
- 110 Pages
Global
From €5297EUR$5,950USD£4,628GBP
- Report
- April 2025
- 140 Pages
Global
From €5297EUR$5,950USD£4,628GBP
- Report
- April 2025
- 255 Pages
Global
From €4941EUR$5,550USD£4,317GBP
- Report
- April 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,493GBP
- Report
- March 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,493GBP
- Report
- March 2025
- 200 Pages
Global
From €3997EUR$4,490USD£3,493GBP
- Report
- October 2025
- 138 Pages
Global
From €2269EUR$2,549USD£1,983GBP
€2670EUR$2,999USD£2,333GBP
- Report
- September 2025
- 139 Pages
Global
From €2269EUR$2,549USD£1,983GBP
€2670EUR$2,999USD£2,333GBP
- Report
- September 2025
- 141 Pages
Global
From €2269EUR$2,549USD£1,983GBP
€2670EUR$2,999USD£2,333GBP
- Report
- August 2025
- 136 Pages
Global
From €2269EUR$2,549USD£1,983GBP
€2670EUR$2,999USD£2,333GBP
- Report
- April 2025
- 141 Pages
Global
From €2269EUR$2,549USD£1,983GBP
€2670EUR$2,999USD£2,333GBP
- Report
- March 2025
- 144 Pages
Global
From €2269EUR$2,549USD£1,983GBP
€2670EUR$2,999USD£2,333GBP
- Report
- January 2025
- 131 Pages
Global
From €2269EUR$2,549USD£1,983GBP
€2670EUR$2,999USD£2,333GBP
- Report
- January 2025
- 143 Pages
Global
From €2269EUR$2,549USD£1,983GBP
€2670EUR$2,999USD£2,333GBP

Glaucoma is a group of eye diseases that damage the optic nerve, leading to vision loss. It is the leading cause of irreversible blindness worldwide. The glaucoma market within the optical industry is focused on providing treatments and technologies to diagnose and manage the disease. This includes medications, laser treatments, and surgical procedures. Additionally, the market includes devices such as tonometers, optical coherence tomography (OCT) systems, and visual field analyzers. These devices are used to measure intraocular pressure, detect structural changes in the eye, and assess the extent of vision loss.
Companies in the glaucoma market include Allergan, Bausch + Lomb, Carl Zeiss Meditec, Ellex, Glaukos, Hoya, Nidek, Topcon, and Ziemer Ophthalmic Systems. Show Less Read more